GlassScriptPhysician profile
Huy D Khuu
NPI 1922043157
$17,577.61
in general payments reported to CMS, 2019-2025
40 companies · $1,255 in 2025
The $1,255 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,612 · 2020: $2,535 · 2021: $4,135 · 2022: $4,826 · 2023: $1,190 · 2024: $1,024 · 2025: $1,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,468.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $8,288.35 | 2019-2025 | Orsiro Mission, Acticor 7 Vr-T Dx |
| Astrazeneca Pharmaceuticals LP | $1,082.34 | 2019-2023 | Farxiga |
| Abbott Laboratories | $915.53 | 2019-2024 | Diamondback Peripheral, Perclose Prostyle |
| Medtronic, INC. | $895.27 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan |
| Pfizer INC. | $702.95 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $615.35 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $572.70 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $549.61 | 2019-2020 | |
| Boston Scientific Corporation | $426.37 | 2020-2025 | Latitude Communicator Power Supply, Lux-Dx Insertable Cardiac Monitor, Ingevity+ |
| Amgen INC. | $366.87 | 2019-2025 | Repatha, Repatha |
| Inari Medical, INC. | $361.92 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cathworks, INC. | $344.69 | 2025 | Ffrangio |
| Novartis Pharmaceuticals Corporation | $327.48 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $307.61 | 2019-2025 | Jardiance |
| Abiomed | $278.43 | 2020-2023 | Impella |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $252.36 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $240.48 | 2019-2024 | Camzyos, Eliquis |
| Chiesi USA, INC. | $179.83 | 2019-2021 | |
| Elutia, INC. | $170.04 | 2020-2024 | Ecm Patch,Pouch |
| Edwards Lifesciences Corporation | $79.81 | 2019-2020 | |
| Cvrx, INC. | $72.06 | 2022-2024 | Barostim Neo System |
| Acist Medical Systems, INC. | $61.50 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $57.56 | 2019-2021 | |
| Amarin Pharma, INC. | $48.23 | 2020-2021 | |
| Cardiovascular Systems INC. | $46.63 | 2020-2022 | |
| Astellas Pharma US INC | $40.70 | 2021 | |
| Stryker Corporation | $31.33 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Scpharmaceuticals INC. | $27.37 | 2025 | |
| Kestra Medical Technology Services, INC. | $25.96 | 2022 | |
| Terumo Medical Corporation | $23.51 | 2024 | Angio-Seal |
| Merck Sharp & Dohme LLC | $22.55 | 2021 | |
| Shockwave Medical, INC | $22.16 | 2025 | |
| Philips North America LLC | $20.10 | 2024 | (Ck4) Mcot |
| Thrombolex, INC. | $19.46 | 2024 | Bashir Endovascular Catheter |
| Kiniksa Pharmaceuticals International, Plc | $18.95 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $18.94 | 2022 | |
| Novo Nordisk INC | $17.78 | 2025 | Wegovy |
| Irhythm Technologies, INC. | $17.68 | 2022 | |
| Glaxosmithkline, LLC. | $15.90 | 2025 | Arexvy, Shingrix |
| Medicomp INC | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huy Khuu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.